Section search
Enter a keyword or phrase to search all pages in this section:
Advanced searchArchive:
Looking for a previously published document in this section?
| Type: | Medical Device Alert |
|---|---|
| Series No: | MDA/2010/004 |
| Audience: | Healthcare professionals |
| Published: | 11 January 2010 at 11:00 |
| Format: | Electronic only |
| Size: | A4 |
| Pages: | 5 |
| Price: | Free |
| ISBN/ISSN: | |
| Author: | |
| Copyright: | Crown |
MHRA pages:
Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Ref: MDA/2010/004 | Issued: 11 January 2010 at 11:00
If you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2010/004 or 2007/010/005/401/005 or 2006/008/029/301/003 or 2009/001/020/301/002 or 2007/006/018/061/029.
Ed Ball or James McVeigh
Medicines and Healthcare products Regulatory Agency
Centre for Assistive Technology
241 Bristol Avenue
Bispham
Blackpool
FY2 0BR
Tel: 01253 596 000
Fax: 01253 596 177
Email: bav@mhra.gsi.gov.uk
How to report adverse incidents
Please report via our website: Reporting adverse incidents involving medical devices.
Further information about CAS can be found on the Central Alerting System website (external link).
Alerts in Northern Ireland will continue to be distributed via the NI SABS system.
Enquiries and adverse incident reports in Northern Ireland should be addressed to:
Northern Ireland Adverse Incident Centre (NIAIC)
Health Estates
Estate Policy Directorate
Stoney Road
Dundonald
Belfast
BT16 1US
Tel: 02890 523 704
Fax: 02890 523 900
Email: NIAIC@dhsspsni.gov.uk
Northern Ireland Adverse Incident Centre (NIAIC) (external link)
How to report adverse incidents in Northern Ireland
Please report directly to NIAIC, further information can be found on the NIAIC website (external link).
Further information about SABS can be found on the SABS website (external link).
Enquiries and adverse incident reports in Scotland should be addressed to:
Incident Reporting and Investigation Centre
Health Facilities Scotland
NHS National Services Scotland
Gyle Square
1 South Gyle Crescent
Edinburgh
EH12 9EB
Tel: 0131 275 7575
Fax: 0131 314 0722
Email: nss.iric@nhs.net
Health Facilities Scotland - Incident Reporting and Investigation Centre (external link)
Enquiries in Wales should be addressed to:
Dr Sara Hayes
Senior Medical Officer
Medical Device Alerts
Welsh Assembly Government
Cathays Park
Cardiff
CF10 3NQ
Tel: 029 2082 3505 / 3922
Email: Haz-Aic@wales.gsi.gov.uk
Action 3 and Action 4 manual wheelchairs manufactured by Invacare.

These wheelchairs have been on sale in the UK since 2004. All models are affected, including wheelchairs fitted with Comfort seating.
Invacare has revised the instructions for use for various safety related aspects.
Users who are unaware of these revised instructions are at risk of injury. In particular, from a fall due to instability or from positional asphyxiation due to poor lap belt position, fitting or adjustment.
The MHRA is aware of several reports relating to different aspects of the Action 3 and Action 4 wheelchairs. Injuries have been reported in relation to some of these issues. Invacare has revised the content of the instructions for use (IFU) for these models but has not provided them to all existing users. There is potential for serious injury to users or others if the revised IFU are not adhered to.
The Action 3 and Action 4 IFU have now been updated with the following additions:
The updated IFU for both models are available from Invacare UK or can be downloaded from the Invacare website (external link).
Invacare has already produced one Field Safety Notice (FSN 020) concerning the removal of tie-down labels on Action 3 wheelchairs. Invacare has also agreed to issue further Field Safety Notices for the Action 3 and Action 4 to cover the additional items shown above, but has not yet provided issue dates for these.
This MDA has been distributed to:
Onward distribution
Please bring this notice to the attention of all who need to know or be aware of it. This may include distribution by:
Trusts to:
CAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:
Care Quality Commission (CQC) (England only) to:
The MHRA considers this information to be important to:
OFSTED to:
The MHRA considers this to be important to:
Primary care trusts to:
CAS liaison officers for onward distribution to all relevant staff including:
Social services to:
Liaison officers for onward distribution to all relevant staff including:
Technical Services Department
Invacare UK Operations Ltd
South Road
Bridgend Industrial Estate
Bridgend
CF31 3PY
Tel: 01656 647 327
Fax: 01656 753 299
Email: UK@invacare.com